Advertisement
Not a member of Pastebin yet?
Sign Up,
it unlocks many cool features!
- Cover
- Contents
- Editorial Team
- Principal Editors
- International Editors
- Specialist Advisory Editors
- Authors
- Beginnings
- Foreword to the First Edition
- Foreword to the Second Edition
- Preface
- Acknowledgements
- 1: Neurology Worldwide: The Epidemiology and Burden of Neurological Disease
- Epidemiology of neurological disease
- Frequency and distribution of neurological disease
- Causation
- Mortality
- Other measures and rates
- Burden of illness
- Definitions
- Cost of illness studies
- WHO burden of illness studies
- The personal burden of neurological disease – stigma
- Relative costs – developing countries
- Treatment gap
- References
- Further reading
- 2: Nervous System Structure and Function
- BASIC NEUROSCIENCE
- Introduction
- The functional unit: the neurone
- Amyloid and tau in Alzheimer’s disease
- Neurotransmission
- Electrical synapses
- Chemical synapses
- Types of CNS synapse
- Peripheral nervous system synapses
- Neuromuscular junction
- Neurotransmitters
- Transmitter release
- Transmitter‐gated ion channels and G‐protein‐coupled receptors
- Glia
- Astrocytes
- Oligodendrocytes (oligodendroglia)
- Microglia
- Ependyma
- Schwann cells
- Peripheral nerve fibre types
- Myelin and saltatory conduction
- Composition of the myelin sheath
- Glycoproteins
- Basic proteins
- Other proteins
- Myelination and axon–Schwann cell interactions
- Sensory nerve endings
- Muscle spindle motor supply, annulospiral and flower spray endings
- Golgi tendon organs
- THE WORKING BRAIN
- Introduction
- Mechanisms of movement
- Three central systems of motor control
- Corticospinal (pyramidal) system
- Afferents to the primary motor cortex
- Basal ganglia and ‘extrapyramidal’ movement disorders
- Basic circuits within the basal ganglia
- Other basal ganglia circuits
- Cerebellum
- Sensation and sensory pathways
- Conscious and non‐conscious sensation
- Somatic sensory pathways in the cord and brain
- Dorsal root ganglia – first order neurones
- Termination of dorsal root afferents
- Posterior column
- medial lemniscus pathway
- Spinothalamic pathway
- Other ascending sensory pathways
- The brainstem
- Brainstem functions
- Motor fibres
- Motor fibres to cranial nerve nuclei
- Sensory pathways within the brainstem
- Spinothalamic tracts
- Posterior column
- medial lemniscus
- Vth nerve central pathways
- Clinical correlates
- Cranial nerve nuclear columns
- Reticular formation
- Essential anatomy
- Respiratory control
- Sleep, wakefulness and mood
- Cardiovascular control
- Patterns of primitive movements
- Micturition control
- Gate control: sensory modulation
- Limbic system, hippocampus and related structures
- Afferent hippocampal connections
- Efferent hippocampal connections
- Declarative memory and long‐term potentiation
- Insula, cingulate cortex and parahippocampal gyrus
- Amygdala
- Nucleus accumbens
- Septal region
- Basal forebrain
- The thalamus
- Cortical connections
- Specific (relay) thalamic nuclei
- Association thalamic nuclei
- Non‐specific thalamic nuclei
- Hypothalamus and pituitary gland
- Arterial and capillary supply
- Neuroendocrine cells
- Anterior pituitary axis
- Posterior pituitary axis
- Circumventricular organs
- Sympathetic and parasympathetic hypothalamic activity
- Temperature regulation
- Water intake and thirst
- Appetite and satiety
- Mood, sexual arousal, wakefulness and memory
- Cranial nerves
- Olfactory nerve and its cortical connections
- Olfactory epithelium
- Olfactory bulb and tract
- Cortical connections
- Neurotransmission in the olfactory system
- Optic nerve and visual system
- Retinal structure
- Optic nerve, chiasm and optic tract
- Optic radiation
- Occipital cortex
- Visual association cortex and V1–V5 terminology
- Cortical eye fields
- Gaze centres in the brainstem
- The light reflex: pupil constriction
- III, IV and VI: third, fourth and sixth nerve nuclei and nerves
- Oculomotor nucleus and IIIrd nerve
- Trochlear nucleus and IVth nerve
- Abducens nucleus and VIth nerve
- The near response
- The far response
- Sympathetic pathway to the eye and face
- V: trigeminal nerve, sensory and motor nuclei
- Motor nucleus of V and supratrigeminal nuclei
- Sensory Vth nuclei
- Mesencephalic Vth nucleus
- Principal (pontine) Vth nucleus
- Spinal Vth nucleus
- Trigeminothalamic tract, lemniscus, cortical projection and reticular formation
- VII: facial nerve
- Nervus intermedius, greater petrosal nerve and chorda tympani
- VIII: vestibulocochlear nerve
- Vestibular system
- Auditory system
- Cochlear nerve and central connections
- IX, X, XI and XII: glossopharyngeal, vagus, accessory and hypoglossal nerves
- XI: spinal accessory nerve
- Cranial accessory XI, glossopharyngeal IX and vagus X – and their nuclei
- Glossopharyngeal nerve IX
- Vagus nerve X
- XII: hypoglossal nerve
- Autonomic nervous system
- Sympathetic system
- Parasympathetic system
- Cranial parasympathetic III, VII, IX and X fibres and subsequent ganglia
- Sacral parasympathetic fibres and ganglia
- Neurotransmission within the autonomic system
- Neurotransmission at sympathetic and parasympathetic ganglia
- Neuro‐effector junction transmission at target tissues
- Junctional receptors at target tissues
- Other autonomic neurotransmitter systems
- Acknowledgements
- Further reading
- 3: Mechanisms of Neurological Disease: Genetics, Autoimmunity and Ion Channels
- Genetics
- Modes of inheritance
- Autosomal dominant inheritance
- Autosomal recessive inheritance
- Sex‐linked inheritance
- Mitochondrial disorders
- Expanded repeat disorders
- How heritable are neurological conditions? Lessons from twins
- Mutation versus polymorphism
- The discovery process
- Practical considerations
- Ethical considerations: predictive versus diagnostic
- Incidental findings in diagnostic exome and genome sequencing
- Autoimmunity
- Fundamentals
- Components of the immune system
- Innate immune system
- Adaptive immune system
- Protection of neural tissues – the blood–brain and blood–nerve barriers
- Intrathecal antibody synthesis and the blood–brain barrier
- Analysis of CSF solutes
- Immune diseases of the nervous system
- Antibody‐mediated neurological diseases
- T‐cell mediated neurological disease
- Cytokine‐driven processes
- Interfering with the immune system as a treatment for disease
- Inherited mutations of ion channels
- Channelopathies
- Migraine
- Epilepsy
- Movement disorders and ataxia
- Disorders of peripheral nerve and autonomic function
- Muscle disease
- Psychiatric and cognitive disorders
- Disease causation in channelopathies
- Potassium channels
- Transient receptor potential channels
- Sodium channels
- Calcium channels
- Chloride channels
- Ligand‐gated ion channels
- Acquired versus inherited channelopathies
- References
- Further reading
- Genetics
- Immunology
- Channelopathies
- 4: The Language of Neurology: Symptoms, Signs and Basic Investigations
- Elements of diagnosis
- History
- Nature of symptoms
- Neurological examination
- Preliminary assessment
- Brief neurological examination
- Detailed neurological examination
- Cognition and mental state
- Skull, scalp and spine
- Cranial nerves
- I: olfaction
- II: vision, pupils and fundi
- III, IV and VI: eye movements
- V: trigeminal nerve – sensory and motor
- VII: facial nerve
- VIII: auditory nerve
- VIII: vestibular nerve
- IX and X: glossopharyngeal and vagus nerves
- XI: accessory nerve
- XII: hypoglossal nerve
- Gait and disorders of movement
- Motor system
- Posture of outstretched upper limbs
- Tone
- Power, muscle bulk and consistency
- Coordination – cerebellar signs
- Tendon reflexes
- Lower and upper motor neurone lesions
- Sensory system
- Formulation and diagnosis
- Difficulties with the history and examination
- Diagnostic tests in clinical neurology
- Imaging
- Conventional radiography (plain X‐rays)
- Computerised tomography
- Magnetic resonance imaging
- Clinical neurophysiology
- Electroencephalography
- Magneto‐encephalography and transcranial magnetic brain stimulation
- Clinical neurophysiological studies of nerve and muscle
- Electromyography
- Peripheral nerve conduction studies
- Neuromuscular transmission studies
- Cerebral‐evoked potentials
- Specialised blood and urine tests
- Cerebrospinal fluid examination
- Indications for LP and CSF examination
- LP technique
- Biopsy of brain, nerve and muscle
- Neuropsychological testing
- Intellectual function overall
- Formulation and conclusions
- Terminology, or vocabulary of clinical neurology
- Focal cortical disorders
- Language (and speech) disorders
- Temporal lobe lesions
- Frontal lobe lesions
- Occipital lobe lesions
- Parietal lobe lesions
- Motor abnormalities: brain and spinal cord
- Hemiparesis
- Cerebellar syndromes
- Disorders of movement
- Paraparesis
- Brainstem syndromes
- Anterior horn cell disease
- Sensory abnormalities: patterns at different levels
- Peripheral nerve lesions
- Sensory root and root entry zone lesions
- Spinal cord lesions
- Sensory changes in brainstem lesions
- Sensory changes following thalamic lesions
- Sensory changes in parietal lobe lesions
- Mononeuropathy, polyneuropathy, root lesions
- Mononeuropathy
- Multiple mononeuropathy
- Polyneuropathy
- Neurogenic muscle wasting
- Root lesions
- Cauda equina syndrome
- Myopathy
- Subacute paralytic conditions
- Unexplained symptoms, abnormal illness behaviour and somatoform disorder
- References
- Further reading
- General neurology, examination, classic works
- Nerve conduction and electromyography
- Electroencephalography
- CSF examination
- Neuropsychiatry
- Neuropsychology screening tests
- Imaging
- 5: Stroke and Cerebrovascular Diseases
- Epidemiology
- Clinical approach to stroke
- Ischaemic stroke
- Important vascular anatomy
- Heart and great vessels
- Extracranial and intracranial arteries
- Venous anatomy
- Pathophysiology of ischaemic stroke
- Thrombosis, embolism and hypoperfusion
- Microscopic and metabolic changes
- Ischaemic penumbra
- Pressure changes
- Risk factors and causes of ischaemic stroke
- Age, hypertension, smoking, lipids and drug misuse
- Cardiac disease
- Stroke and the blood
- Antiphospholipid antibodies and syndrome
- Clinical syndromes of cerebral ischaemia
- Transient ischaemic attacks
- Alternative diagnoses
- Lacunar stroke
- Rarer causes of lacunar syndromes
- Large vessel occlusion
- Internal carotid artery disease
- Middle cerebral artery occlusion
- Anterior cerebral artery occlusion
- Anterior choroidal artery occlusion
- Posterior cerebral artery
- Vertebral artery
- Basilar artery
- Border‐zone syndromes and ischaemic encephalopathy
- Vascular dementia
- Intracranial haemorrhage
- Risk factors
- Clinical syndromes of intracranial haemorrhage
- Deep haemorrhage
- Lobar haemorrhage
- Infratentorial haemorrhage
- Intraventricular haemorrhage
- Specific issues in intracerebral haemorrhage
- Prognosis of intracranial haemorrhage
- Subarachnoid haemorrhage
- Risk factors
- Clinical features
- Investigation
- Initial management
- Aneurysm treatment
- Management of complications
- Outcome
- Arteriovenous malformations
- Presentation
- Natural history
- Management
- Cavernous malformations
- Dural fistulae
- Investigation of stroke and TIAs
- Basic investigations for all: simple tests
- Imaging
- Guided investigations following basic profile
- Cardiac investigations
- Special investigations
- Management of acute stroke
- Organised care in a stroke unit
- Specific treatments for acute ischaemic stroke
- Thrombolysis
- Mechanical recanalisation
- Antiplatelet therapy in acute stroke
- Anticoagulation in thrombo‐embolic stroke
- Neuroprotection
- Maintenance of homeostasis
- Treatment of cerebral oedema
- Management of progressive stroke
- Common medical complications of stroke
- Secondary prevention
- Secondary prevention after TIA and stroke
- Lifestyle modification
- Lowering blood pressure
- Diabetes mellitus
- Lowering cholesterol
- Anticoagulation
- Antiplatelet therapy
- Management of carotid stenosis
- Symptomatic carotid stenosis
- Asymptomatic carotid stenosis
- Carotid stenting
- Vertebral stenosis
- Intracranial artery stenosis
- Non‐atherosclerotic vascular disease and other rarer causes of stroke
- Carotid and vertebral artery dissection
- Vasculitis
- Infective vasculitis
- Systemic vasculitides
- Collagen vascular disease
- Other vasculitis
- Isolated angiitis of the central nervous system
- Thrombotic thrombocytopenic purpura
- Behçet’s disease
- Susac’s syndrome
- Sneddon’s syndrome
- Mitochondrial disease
- Fabry disease
- CADASIL and CARASIL
- Hypertensive encephalopathy
- Migraine and stroke
- Moyamoya angiopathy
- Cerebral venous thrombosis
- Reversible cerebral vasoconstriction syndrome
- Vascular disease of the spinal cord
- Stroke: overall conclusions
- References
- Further reading
- Anticoagulation
- Arteriovenous malformations
- Atrial fibrillation
- CADASIL
- Carotid stenosis
- Causes of stroke
- Cavernous angiomas
- Cerebral amyloid angiopathy
- Dissection
- Fabry’s disease
- Endovascular treatment of hyperacute stroke
- Fibromuscular dysplasia
- Haematological disorders
- Hypertension
- Incidence, prevalence and prognosis
- Inflammatory vascular disorders
- Mitochondrial disease and MELAS
- Moyamoya syndrome
- Patent foramen ovale
- Radiology
- Secondary prevention
- Stroke definition
- Stroke units and organisation
- Subarachnoid haemorrhage
- Surgical treatment
- Thrombolytic therapy
- Transient ischaemic attack
- Venous thrombosis
- 6: Movement Disorders
- Parkinsonian (akinetic‐rigid) syndromes
- Cardinal motor features of parkinsonism
- Parkinson’s disease
- Premotor features of PD
- Typical’ motor presentation of PD
- Non‐motor features of PD
- Ancillary investigations
- Treatment of PD
- Levodopa
- Monoamine oxidase B inhibitors
- Catechol‐
- methyl transferase inhibitors
- Dopamine agonists
- Anticholinergics
- Amantadine
- Surgery for PD
- Dementia in association with Lewy body pathology
- Multiple system atrophy
- Progressive supranuclear palsy
- Corticobasal degeneration
- Ancillary investigations to distinguish between PD, MSA, PSP and CBD and other conditions
- Vascular parkinsonism
- Ethnic or region‐specific parkinsonism
- Other causes of parkinsonism
- Tremor
- Benign essential tremor
- Dystonic tremor
- Neuropathic tremor
- Fragile X tremor ataxia syndrome
- Cerebellar (pathway) tremor
- Intention tremor
- Holmes tremor
- Palatal tremor
- Orthostatic tremor
- Drug and toxin‐induced tremor
- Psychogenic tremor
- Dystonia
- Epidemiology
- Classifying dystonia
- Primary dystonia
- Dystonia‐plus syndromes
- Dopa‐responsive dystonia
- Myoclonus dystonia
- Symptomatic dystonia
- Heredodegenerative dystonias
- Wilson’s disease
- Clinical presentations
- Diagnosis
- Treatment
- Paroxysmal dyskinesias
- Investigation of dystonia
- Treatment of dystonia
- Surgery for dystonia
- Chorea
- Assessment of chorea
- Huntington’s disease
- Clinical features
- Juvenile Huntington’s disease
- Differential diagnosis of Huntington’s disease
- Neuro‐acanthocytosis
- Post‐streptococcal autoimmune disorders
- Benign hereditary chorea
- Drug‐induced chorea
- Drug management of chorea
- Tics
- Gilles de la Tourette syndrome
- Epidemiology, history and prevalence
- Psychopathology and associated co‐morbidity
- Assessment
- Current aetiological theories
- Multiple phenotypes of GTS
- Other forms of tic disorder
- Other diseases that can cause tics
- Investigation of tics
- Management of GTS and tics
- Myoclonus
- Physiological myoclonus
- Essential myoclonus
- Epileptic myoclonus
- Familial cortical tremor (also called benign autosomal dominant familial myoclonic epilepsy)
- Epilepsia partialis continua
- Secondary myoclonus
- Non‐progressive myoclonic encephalopathies
- Post‐anoxic action myoclonus (Lance–Adams syndrome)
- Opsoclonus myoclonus
- Myoclonus in neurodegenerative disorders
- Subcortical myoclonus
- Startle syndromes
- Palatal myoclonus
- Spinal myoclonus
- Peripheral myoclonus
- Psychogenic myoclonus
- Drug‐induced myoclonus
- Treatment of myoclonus
- Other movement disorders
- Psychogenic (functional) movement disorders
- Movement disorders associated with dopamine receptor blockade or dopamine depletion
- Restless legs syndrome
- Painful legs and moving toes
- Stiff person syndrome, stiff limb syndrome and encephalomyelitis with rigidity
- Neurophysiological assessment of movement disorders
- Neurophysiological assessment of tremor
- Neurophysiological assessment of dystonia
- Neurophysiological assessment of myoclonus
- Cortical myoclonus
- Reticular, or brainstem, myoclonus
- Spinal myoclonus
- Further reading
- Parkinson’s disease and related disorders
- Chorea
- Wilson’s disease
- Dystonias
- Tics
- Tremor
- Myoclonus
- Psychogenic movement disorders
- Other movement disorders
- 7: Epilepsy and Related Disorders
- Definitions
- Epidemiology
- ILAE classification of seizure type
- Partial (focal) seizures
- Simple partial seizures
- Complex partial seizures
- Generalised seizures
- Typical absence seizure (petit mal seizure)
- Atypical absence seizure
- Myoclonic seizure
- Clonic seizure
- Tonic seizure
- Tonic–clonic seizure (grand mal seizure)
- Atonic seizure
- ILAE classification of the epilepsies and epilepsy syndromes
- Idiopathic generalised epilepsy
- Childhood absence epilepsy
- Juvenile myoclonic epilepsy
- Epilepsy with grand mal seizures on awakening
- Benign partial epilepsy syndromes
- Benign partial epilepsy with centrotemporal spikes
- Early onset benign occipital epilepsy (
- Panayiotopoulos syndrome)
- West syndrome
- Lennox–Gastaut syndrome
- Febrile seizures
- Causes of epilepsy
- Idiopathic epilepsy
- Pure epilepsies resulting from single gene disorder
- Pure epilepsies with complex inheritance
- Symptomatic epilepsy
- Inborn errors of metabolism
- Progressive myoclonic epilepsy
- Epilepsies in neurocutaneous syndromes
- Cortical dysplasia
- Hippocampal sclerosis
- Cerebral palsy, perinatal and prenatal injury
- Post‐vaccination encephalopathy
- Cerebral tumour
- Cerebrovascular disease
- Arteriovenous malformation
- Cavernous haemangioma (cavernoma)
- Other vascular lesions
- Dementia and degenerative disorders
- Post‐traumatic epilepsy
- Epilepsy after neurosurgery
- Bacterial or viral meningitis and encephalitis
- Parasitic diseases
- Inflammatory and immunological disorders
- Differential diagnosis of epilepsy
- Loss of awareness and collapse
- Epilepsy
- Syncope
- Cardiac syncope
- Dissociative seizures
- Panic attacks
- Hypoglycaemia
- Other neurological disorders
- Generalised convulsive movements
- Epilepsy
- Syncope with myoclonic jerking movements
- Primary cardiac or respiratory abnormalities presenting with secondary anoxic seizures
- Involuntary movement disorders and other neurological conditions
- Hyperekplexia
- Dissociative seizure
- Focal convulsive movements
- Focal motor seizures
- Tics
- Transient cerebral ischaemia
- Tonic spasms of multiple sclerosis
- Paroxysmal movement disorders
- Transient facial muscle and eye movements
- Partial seizures
- Movement disorders
- Other neurological disorders
- Drop attacks
- Epilepsy
- Cardiovascular causes
- Movement disorders
- Brainstem, spinal or lower limb abnormalities
- Cataplexy
- Metabolic disorders
- Idiopathic drop attacks
- Vertebrobasilar ischaemia
- Transient focal sensory symptoms
- Transient vestibular symptoms
- Transient visual symptoms
- Transient psychic experiences
- Epilepsy
- Migraine
- Panic attacks
- Drug‐induced flashbacks
- Hallucinations or illusions caused by loss of a primary sense
- Psychotic hallucinations and delusions
- Dissociative seizures
- Aggressive outbursts
- Episodic phenomena in sleep
- Normal physiological movements
- Frontal lobe epilepsy
- Other epilepsies
- Pathological fragmentary myoclonus
- Restless leg syndrome
- Non‐REM parasomnia
- REM parasomnia
- Sleep apnoea
- Other movements in sleep
- Prolonged confusional or fugue states
- Acute encephalopathy
- Non‐convulsive status epilepticus
- Intermittent psychosis
- Transient global amnesia
- Hysterical fugue
- Investigation of epilepsy
- Routine tests to carry out in all cases
- Biochemical, haematological and immunological tests
- Electroencephalography
- EEG in the diagnosis of epilepsy
- Epileptiform phenomena
- EEG in the classification of epileptic seizures and syndromes
- EEG and prediction of seizure recurrence
- EEG and withdrawal of antiepileptic medication
- EEG and antiepileptic drugs
- Long‐term EEG monitoring
- Neurophysiology for assessing patients for epilepsy surgery
- EEG and tonic–clonic status epilepticus
- Non‐convulsive status epilepticus
- EEG in the intensive care setting
- EEG and cognitive deterioration
- Imaging in epilepsy
- X‐ray computed tomography
- Magnetic resonance imaging
- Functional magnetic resonance imaging
- Tractography
- Single‐photon emission computed tomography
- Positron emission tomography
- Medical treatment
- Principles of treatment of newly diagnosed patients
- Diagnosis
- Risk of recurrence of seizure
- Type, timing and frequency of seizure
- A protocol for initial treatment
- Treatment protocol for patients with chronic epilepsy
- Assessment
- Treatment plan
- Limits of therapy
- Choice of drugs and details of antiepileptic drugs
- Monotherapy versus combination therapy
- Role of antiepileptic drug level measurements
- Patient information
- Treatment of patients with epilepsy in remission
- Discontinuation of drug therapy
- How to withdraw therapy – the importance of slow reduction
- Management of epilepsy in learning disability
- Definition
- Prevalence of epilepsy in people with learning disability
- Assessment
- Diagnostic difficulties
- Treatment
- Management in the elderly
- Causes of epilepsy
- Diagnosis and investigations
- Medical treatment
- Antiepileptic drug treatment
- Acetazolamide
- Benzodiazepines
- Carbamazepine
- Eslicarbazepine acetate
- Ethosuximide
- Felbamate
- Gabapentin
- Lacosamide
- Lamotrigine
- Levetiracetam
- Oxcarbazepine
- Perampanel
- Phenobarbital
- Phenytoin
- Piracetam
- Pregabalin
- Primidone
- Retigabine
- Rufinamide
- Stiripentol
- Tiagabine
- Topiramate
- Valproate
- Vigabatrin
- Zonisamide
- Emergency drug treatment
- Prolonged convulsions or serial seizures
- Status epilepticus
- Treatment of non‐convulsive status epilepticus
- Treatment of convulsive status epilepticus
- Stage of early status epilepticus
- Stage of established status epilepticus
- Stage of refractory status epilepticus
- Stage of super‐refractory status epilepticus
- Epilepsy surgery
- Who is suitable for presurgical assessment?
- Presurgical assessment
- Clinical history
- Psychiatric history
- Neuroimaging
- Electroencephalography and other neurophysiological investigations
- Neuropsychology
- Counselling
- Surgery
- Curative resective surgery
- Palliative procedures
- Follow‐up and prognosis
- Driving regulations in the UK
- Group 1 licensing
- Group 2 licensing
- For both types of licence
- Role of the doctor vis‐à‐vis the driving regulations
- Other types of vehicle
- Acknowledgement
- References
- Further reading
- Useful websites with epilepsy information for patients
- Books
- Journal articles
- 8: Dementia and Cognitive Impairment
- Epidemiology: Delirium, dementia and cognitive impairment
- Cognitive functions and their clinical syndromes
- Attention
- Memory
- Paramnesias
- Transient global amnesia
- Perception
- Hallucinations
- Knowledge
- Voluntary action
- Speech and language
- Literacy and numeracy
- Executive function
- Emotion
- Investigation of the patient with cognitive impairment
- Basic principles
- Initial investigation
- Neuropsychometry
- Brain imaging
- Electroencephalography
- Cerebrospinal fluid examination
- Additional investigations
- The dementias
- Alzheimer’s disease
- Clinical features and assessment
- Investigations
- Management
- Frontotemporal dementia
- Behavioural variant frontotemporal dementia
- Semantic dementia
- Progressive non‐fluent aphasia
- Investigations
- Genetic pathological correlations
- Prognosis
- Management
- Dementia with Lewy bodies and Parkinson’s disease dementia
- Dementia with other movement disorders
- Prion disease
- Introduction and disease biology
- Aetiological categories and classification of human prion disease
- Sporadic prion disease
- Acquired prion diseases
- Inherited prion diseases
- Prevention and treatment
- Vascular dementia and vascular cognitive impairment
- Dementia in young adults
- Potentially reversible causes of dementia
- Neoplasms and other space‐occupying lesions
- Epilepsy and dementia
- Limbic encephalitis
- Infective, metabolic, toxic and other causes of dementia
- Controversial entities
- Management of dementia
- Risk factor management
- Co‐morbidity
- Behavioural management
- Safety
- Caring for the carer
- Planning for the future and end of life issues
- References
- Further reading
- Epidemiology
- Cognitive function and clinical syndromes
- Investigations
- Alzheimer’s disease
- Frontotemporal lobar degeneration
- Vascular cognitive impairment
- Parkinson’s disease dementia and dementia with Lewy bodies
- Dementia in young adults: general
- Others
- Management
- Treatment of Alzheimer’s disease
- 9: Infection in the Nervous System
- Bacterial meningitis
- Epidemiology
- Pathogenesis
- Clinical presentation
- Investigation
- Management
- Specific causes of bacterial meningitis
- meningococcal meningitis)
- pneumococcal meningitis)
- type b
- Group B streptococcus
- Gram‐negative meningitis
- Gram‐positive meningitis (non‐pneumococcal, non‐group B)
- Nosocomial meningitis
- Focal CNS infection
- Cerebral abscess
- Clinical features
- Investigations
- Treatment
- Surgical intervention
- Prognosis
- Subdural empyema
- Pathophysiology
- Causative agents
- Intracranial epidural abscess
- Spinal epidural abscess
- Spinal subdural abscess
- Spinal cord intramedullary abscess
- Infective endocarditis
- Granulomatous infections of the nervous system
- CNS tuberculosis
- Tuberculous meningitis
- Parenchymal CNS tuberculosis
- Tuberculous abscess
- Spinal tuberculosis (tuberculous spondylitis)
- Leprosy (Hansen’s disease)
- Clinical features
- Peripheral nerve involvement
- Borderline leprosy
- Primary neuritic leprosy
- Diagnosis
- Management
- Brucellosis (undulant fever)
- Spirochete CNS infections
- Syphilis
- Late neurosyphilis
- Intracerebral gumma
- Diagnosis
- Treatment
- Zoonoses
- Lyme neuroborreliosis
- Clinical features of early neuroborreliosis
- Early disseminated infection
- Cranial neuropathy
- Acute radiculoneuropathy
- Other syndromes
- Clinical features of late neuroborreliosis
- Post Lyme syndrome
- Diagnosis
- Treatment
- Leptospirosis
- Anthrax
- Psittacosis
- Cat scratch disease
- Infections of the nervous system associated with toxin production
- Diphtheria
- Management
- Botulism
- Forms of botulism
- Clinical presentation
- Diagnosis
- Neurophysiology
- Management
- Tetanus
- Epidemiology
- Clinical features
- Diagnosis
- Differential diagnosis
- Treatment
- Miscellaneous infections of the nervous system
- Mycoplasma
- Whipple’s disease
- Melioidosis
- Tick‐borne disease
- Ehrlichiosis
- Tularaemia
- Rickettsial disease
- Viral infections of the nervous system
- Viral meningitis
- Aetiology
- Clinical features
- Diagnosis
- Viral isolation
- Management and prognosis
- Chronic and recurrent meningitis
- Mollaret’s meningitis
- Encephalitis
- Pathophysiology
- Incidence
- Clinical features
- Diagnosis
- Herpes simplex encephalitis
- Other causes of encephalitis
- Arboviruses (arthropod‐borne viruses)
- Viral haemorrhagic fevers
- Polio and the post‐polio syndrome
- Differential diagnosis
- Prevention
- Post‐polio syndrome
- Subacute sclerosing panencephalitis
- Rabies
- Clinical features
- Diagnosis
- Management
- HTLV‐1
- HTLV‐1 associated myelopathy (tropical spastic paraparesis)
- Other neurological manifestions of HTLV‐1 infection
- HTLV‐2
- Fungal infections
- Risk factors
- True yeasts
- Histoplasmosis
- Coccidiomycosis
- Pseudohyphae
- species
- True hyphae (moulds)
- Mucormycosis
- Parasitic disease of the nervous system
- Neurocysticercosis
- Clinical features
- Diagnosis
- Management
- Trematodes
- Schistosomiasis (bilharzia)
- Protozoa
- American trypanosomiasis (Chagas disease)
- African trypanosomiasis (sleeping sickness)
- Malaria
- Diagnosis
- Acute management
- Prevention
- Neurological disorders resulting from HIV
- Basic principles of neuroAIDS
- Opportunistic infections in HIV
- Tuberculous meningitis and brain abscess
- Cryptococcal meningitis
- Cytomegalovirus infection
- Herpes simplex virus
- Varicella‐zoster virus
- Progressive multifocal leukoencephalopathy
- Primary CNS lymphoma
- Neurological complications resulting directly from HIV
- HIV‐associated neurocognitive disorders
- HIV‐related vacuolar myelopathy
- HIV‐related neuropathy
- Diffuse inflammatory lymphocytosis syndrome
- Toxic neuropathy for antiretroviral drugs
- HIV‐associated myopathy
- Motor neurone disease
- Immune reconstitution inflammatory syndrome
- Conclusions
- Acknowledgement
- References
- Further reading
- Bacterial meningitis
- Tuberculosis
- Syphilis and leprosy
- Toxins
- Zoonoses
- Viral infections
- Tropical diseases
- HIV‐related
- 10: Nerve and Muscle Disease
- Peripheral nerve disorders
- Macro‐anatomy of the peripheral nerve
- Upper limbs
- Lower limbs
- Micro‐anatomy of the peripheral nerve
- Peripheral nerve compartments
- Immunology
- Pathophysiology of the peripheral nerve
- Diseases of the peripheral nerve
- General approach to peripheral nerve disease
- History
- Examination
- Scores
- Neurophysiology
- Nerve biopsy
- Inherited neuropathies
- Charcot–Marie–Tooth disease and related disorders
- An approach to the diagnosis of CMT and related disorders
- Charcot–Marie–Tooth disease
- Hereditary sensory neuropathy
- Distal hereditary motor neuropathy
- Hereditary neuralgic amyotrophy
- Importance of a genetic diagnosis in CMT and related disorders
- Familial amyloid polyneuropathy
- Transthyretin‐related familial amyloid polyneuropathy
- Apolipoprotein A‐1 related FAP
- Gelsolin‐related FAP
- Beta‐2 microglobulin FAP
- Acquired neuropathies
- Inflammatory neuropathies
- Acute neuromuscular weakness and the inflammatory neuropathies
- Guillain–Barré syndrome and its variants
- Chronic inflammatory neuropathies
- Chronic inflammatory demyelinating polyradiculoneuropathy
- CIDP variants
- Paraproteinaemic neuropathies
- Vasculitic neuropathies
- Other acquired peripheral nerve disorders
- Endocrine disorders
- Toxic, nutritional and metabolic peripheral neuropathies
- Metabolic neuropathies
- Critical illness neuromyopathy
- Small fibre neuropathies
- Idiopathic axonal neuropathy
- Focal and compressive neuropathies
- Median nerve compression and carpal tunnel syndrome
- Carpal tunnel syndrome
- Ulnar nerve compression
- Common peroneal neuropathies
- Plexopathies
- Acute brachial neuritis
- Anterior horn cell diseases
- Motor neurone disease
- Amyotrophic lateral sclerosis
- Progressive bulbar palsy
- Flail arm/leg syndrome
- Primary lateral sclerosis
- Progressive muscular atrophy
- Cognitive involvement
- Other forms
- Aetiology
- Diagnosis of MND
- Investigations
- Incidence and prognosis
- Management
- Spinal muscular atrophy
- Genetics and aetiology
- Clinical features
- Investigation
- Management
- Disorders of the neuromuscular junction
- Myasthenia gravis
- Antibody negative’ myasthenia gravis – Anti MuSK antibodies
- Clinical features
- Diagnostic tests
- Management
- Ocular myasthenia gravis
- Pregnancy and myasthenia
- Myasthenic crisis
- Cholinergic crisis
- Anaesthesia and peri‐operative care
- Other causes of abnormal neuromuscular transmission
- Lambert–Eaton myasthenic syndrome
- Clinical features
- Aetiology
- Investigations
- Treatment
- Congenital myasthenia
- Clinical features
- Investigation
- Management
- Muscle diseases
- Basic muscle biology
- Clinical assessment of the patient with muscle disease
- History
- Examination
- Investigation of muscle diseases
- Creatine kinase
- Neurophysiology
- Muscle biopsy
- Metabolic testing
- Genetic testing
- Genetic muscle diseases
- Muscular dystrophies
- Congenital myopathies
- Skeletal muscle channelopathies (Chapter 3)
- Metabolic muscle disease
- Mitochondrial respiratory chain diseases
- Glycogenoses and lipid storage disorders (Chapter 19)
- Acquired muscle diseases
- Inflammatory myopathies
- Idiopathic inflammatory myopathies
- Dermatomyositis
- Polymyositis
- Inclusion body myositis
- Investigation of inflammatory myopathy
- Extended investigation of inflammatory myopathies
- Treatment of idiopathic inflammatory myopathies
- Other rare inflammatory myopathies
- Necrotising autoimmune myopathy
- Drugs and myopathy
- Rhabdomyolysis
- References
- Further reading
- Hereditary neuropathy
- Amyloidosis
- Acquired neuropathies
- Motor neurone disease and spinal muscular atrophy
- Myasthenia gravis
- Muscular dystrophy and congenital myopathies
- Myotonic dystrophy
- Muscle channelopathies
- Mitochondrial disease
- Metabolic muscle disease
- Inflammatory myopathy
- 11: Multiple Sclerosis and Demyelinating Diseases
- Epidemiology
- Migration studies
- Health economics
- Aetiology
- Genetic susceptibility
- Environmental factors
- Transmissible agents
- Vitamin D and sunlight exposure
- Smoking
- Pathophysiology
- Pathology
- Autoimmune pathogenesis
- Clinical course
- Types of multiple sclerosis
- Relapsing remitting multiple sclerosis
- Secondary progressive multiple sclerosis
- Primary progressive multiple sclerosis
- Progressive relapsing multiple sclerosis
- Natural history and prognosis
- Clinically isolated syndrome
- Established multiple sclerosis
- Benign multiple sclerosis
- Aggressive multiple sclerosis
- Early onset multiple sclerosis
- Mortality
- Factors affecting relapse activity
- Infections
- Pregnancy
- Stress
- Vaccines
- Clinical features
- Diagnosis
- Diagnostic investigations
- Magnetic resonance imaging
- Cerebrospinal fluid
- Evoked potentials
- Autoantibodies
- Diagnostic criteria
- Schumacher criteria
- Poser criteria
- McDonald 2001 criteria
- McDonald 2005 criteria
- McDonald 2010 criteria
- Diagnostic criteria for primary progressive multiple sclerosis
- Radiologically isolated syndrome
- Differential diagnosis
- The diagnostic process
- Management
- Education and support
- Management of acute relapses
- Assessment
- Treatment
- Disease‐modifying therapy
- Currently available therapies
- Interferon β and glatiramer acetate
- Interferon β‐1b
- Intramuscular interferon
- Intramuscular interferon β‐1a
- Subcutaneous interferon β‐1a
- PEGylated interferon β
- Glatiramer acetate
- Natalizumab
- Fingolimod
- Teriflunomide
- Alemtuzumab
- Dimethyl fumarate
- Initiation of treatment
- Discontinuation of treatment
- Emerging therapies
- Other therapies
- Future immunomodulatory therapies
- Neuroprotection and remyelination
- Disease‐modifying therapy in primary progressive multiple sclerosis
- Symptomatic treatment
- Fatigue
- Spasticity
- Weakness
- Ataxia
- Bladder and bowel dysfunction
- Sexual dysfunction
- Pain and paroxysmal symptoms
- Cognitive and psychiatric dysfunction
- Visual dysfunction
- Vertigo
- Bulbar and respiratory dysfunction
- Temperature sensitivity
- Neurological rehabilitation
- Vocational rehabilitation
- Palliative care
- Complementary and alternative medicine
- Neuromyelitis optica
- Epidemiology
- Pathophysiology
- Clinical features
- Investigations
- Diagnostic criteria
- Course and natural history
- Management
- Acute para‐infectious inflammatory encephalopathies
- Acute disseminated encephalomyelitis
- Clinical features
- Pathophysiology
- Differential diagnosis
- Investigations
- Clinical course and prognosis
- Management
- Acute haemorrhagic leukoencephalitis
- Clinical features
- Investigations
- Prognosis
- Management
- References
- Further reading
- Epidemiology and aetiology
- Pathophysiology
- Clinical course
- Diagnosis
- Management
- Disease‐modifying therapy
- Symptomatic treatment and neurological rehabilitation
- Neuromyelitis optica
- Acute disseminated encephalomyelitis
- 12: Headache
- Evaluation of the headache patient
- Headache history taking
- Examination of the patient with headache
- Red flags for secondary headaches
- Investigation of the patient with headache
- Secondary headaches
- Medication overuse headache
- Headache caused by vascular disorders
- Subarachnoid haemorrhage
- Carotid and vertebral artery dissection
- Giant cell arteritis
- Headache caused by disturbance of intracranial pressure
- Intracranial hypertension
- Low pressure headaches (intracranial hypotension)
- Primary headaches
- Anatomy and physiology of headache
- Migraine
- Epidemiology
- Clinical features
- Assessment and investigations
- Management
- Tension‐type headache
- Epidemiology
- Clinical features
- Investigations
- Management
- Trigeminal autonomic cephalalgias
- Cluster headache
- Epidemiology
- Clinical features
- Investigations
- Management
- Paroxysmal hemicrania
- Short‐lasting unilateral neuralgiform headache attacks
- Hemicrania continua
- Other primary headaches
- Primary cough headache
- Primary exercise headache
- Primary sex headache
- Primary thunderclap headache
- Primary stabbing headache
- Nummular headache
- Hypnic headache
- New daily persistent headache
- Chronic daily headache
- References
- Further reading
- Background reading
- Classification
- Epidemiology and clinical features
- Investigation
- Specific and unusual headache syndromes
- Treatments
- 13: Cranial Nerve Disorders
- I. Olfactory nerve
- Functional anatomy
- Symptoms
- Examination
- Causes of anosmia
- Ageing
- Upper respiratory infections, nasal and paranasal sinus disease
- Trauma and surgery
- Neurodegenerative disorders
- Other causes of olfactory dysfunction
- V. Trigeminal nerve
- Examination
- Peripheral Vth nerve lesions
- Numb chin syndrome
- Superior orbital fissure syndrome
- Cavernous sinus syndrome
- Nuclear Vth nerve lesions
- Trigeminal neuralgia
- Clinical features
- Aetiology and pathogenesis
- Treatment
- Trigeminal sensory neuropathy
- Herpes zoster ophthalmicus
- Atypical facial pain
- VII. Facial nerve
- Functional anatomy
- Examination
- Supranuclear facial weakness
- Nuclear VIIth lesions
- Cerebellopontine angle syndrome
- Facial canal syndrome
- Lesions at and distal to the stylomastoid foramen
- Bell’s palsy
- Recurrent facial palsy
- Bilateral facial weakness
- Hemifacial spasm
- Other involuntary facial movements
- Lower four cranial nerves: IX, X, XI and XII
- IX. Glossopharyngeal nerve
- Functional anatomy
- Examination
- IXth nerve lesions, peripheral and central
- Glossopharyngeal neuralgia
- X. Vagus nerve
- Functional anatomy
- Clinical features
- Causes and localisation of lesions
- Investigation
- XI. Accessory nerve
- Functional anatomy
- Examination and localisation of lesions
- XIth nerve lesions
- XII. Hypoglossal nerve
- Functional anatomy
- Localisation of lesions
- Causes of XIIth nerve lesions
- Investigation
- Cranial nerve injury following carotid endarterectomy or carotid angioplasty with stenting
- Jugular foramen syndrome
- Bulbar and pseudobular palsy
- Normal swallowing
- Bulbar palsy
- Pseudobulbar palsy
- Dropped head syndrome
- Multiple cranial neuropathies
- Other causes of MCNs
- Intracranial epidural abscess
- Acknowledgement
- References
- Further reading
- Trigeminal nerve (V)
- Facial nerve (VII)
- Bulbar and pseudobulbar palsy
- Glossopharyngeal nerve (IX)
- Accessory nerve (XI)
- Hypoglossal nerve (XII)
- Multiple cranial nerve palsies
- 14: Neuro‐Ophthalmology
- Unilateral visual failure
- History
- Mode of onset
- Positive symptoms
- Effect of light level
- Direct questions
- Examination
- Visual acuity
- Colour vision
- Amsler’s test
- Visual field testing
- Fundus examination
- Associated features
- Bilateral visual failure
- Special investigations in neuroophthalmology
- Optical coherence tomography
- Ultrasound
- Clinical electrophysiology of the eye
- Visual field testing
- Fundus fluorescein angiography
- Optic nerve disease
- Optic neuropathy
- Inflammatory optic neuropathies (optic neuritis)
- Optic neuritis associated with multiple sclerosis
- Optic neuritis associated with neuromyelitis optica (Devic’s syndrome)
- Optic neuritis: chronic relapsing inflammatory optic neuropathy
- Optic neuritis: infective disorders
- Optic neuritis: sarcoid‐related optic neuropathy
- Optic neuritis: neuroretinitis
- Optic neuritis: optic perineuritis
- Ischaemic ocular syndromes
- Nosology of ischaemic syndromes
- Central and branch retinal artery occlusion
- Central and branch retinal vein occlusion
- Non‐arteritic anterior ischaemic optic neuropathy
- Anterior ischaemic optic neuropathy in giant cell arteritis and other vasculitides
- Posterior ischaemic optic neuropathy
- Chronic ocular ischaemic syndromes
- Tumours affecting the optic nerve
- Compressive or infiltrative optic neuropathy
- Optic and optochiasmal glioma
- Hereditary optic neuropathies
- Autosomal dominant optic atrophy
- Leber’s hereditary optic neuropathy
- Toxic and nutritional optic neuropathies
- Traumatic optic neuropathy
- Radiation‐induced optic neuropathy
- Swollen optic disc
- Specific optic disc anomalies
- Papilloedema
- Idiopathic intracranial hypertension
- Ocular involvement in other neurological disease
- Uveomeningitic syndromes
- Neoplasia
- The phakomatoses in neuro‐ophthalmology
- Neurofibromatosis types 1 and 2 (Chapters 16 and 26)
- Von Hippel–Lindau disease (Chapter 26)
- Tuberous sclerosis
- Sturge–Weber syndrome (encephalo‐trigeminal angiomatosis)
- Abnormalities of eye movements
- Diplopia
- Orbital disease
- Thyroid ophthalmopathy
- Orbital inflammatory syndromes
- Cavernous sinus thrombosis
- Carotico‐cavernous fistula
- Myopathy
- Mitochondrial disease
- Oculopharyngeal dystrophy
- Neuromuscular junction abnormalities
- Cranial nerve palsies
- Oculomotor nerve (IIIrd nerve palsy)
- Abducens (V1th) nerve palsy
- Trochlear (IVth) nerve palsy
- Painful and combined ophthalmoplegia
- Central disorders of eye movements
- Saccadic eye movements
- Horizontal gaze palsy
- Vertical gaze palsy
- Oculogyric crises
- Internuclear ophthalmoplegia
- One and a half syndrome
- Wall‐eyed bilateral internuclear ophthalmoplegia
- Internuclear ophthalmoplegia of abduction
- Disconjugate vertical gaze palsy
- Skew deviation and ocular tilt reaction
- Nystagmus
- Horizontal nystagmus
- Nystagmus in normal subjects
- Jerk nystagmus
- Pendular nystagmus
- Nystagmus in childhood
- Pendular nystagmus from visual loss
- Spasmus nutans
- Monocular nystagmus
- Vestibular jerk nystagmus
- Gaze evoked or gaze paretic jerk nystagmus
- Caloric nystagmus
- Torsional nystagmus
- Central vestibular horizontal nystagmus
- Vertical and other forms of nystagmus
- Downbeat nystagmus
- Upbeat nystagmus
- Nystagmus in oculopalatal tremor
- See‐saw nystagmus
- Oculomasticatory myorhythmia
- Periodic alternating nystagmus
- Convergence–retraction nystagmus in Parinaud’s syndrome
- Voluntary nystagmus
- Eye lid nystagmus
- Medical treatment of nystagmus
- Chiasmal and retrochiasmal visual pathways
- Chiasmal disease
- Homonymous hemianopia
- Optic tract
- Lateral geniculate nucleus
- Optic radiation
- Visual cortex
- Bilateral homonymous hemianopia
- Blindsight and stato‐kinetic dissociation
- Visual association areas (extrastriate cortex areas V2–6)
- Disorders of higher visual function
- Visual hallucinations
- Visual hallucinations associated with impaired vision (Charles Bonnet syndrome)
- Peduncular hallucinosis
- Polyopia
- Palinopsia
- Other disorders of visual perception
- Pulfrich’s phenomenon
- Hemifield slide
- Tilt
- Visual synaesthesia
- Visual agnosia
- Prosopagnosia
- Disorders of colour vision
- Cerebral metamorphopsia
- Visual simultanagnosia
- Cortical visual impairment
- Neglect
- Alexia
- Abnormalities of the pupil
- Disorders of the light reflex
- Complete afferent pupillary defect
- Relative afferent pupillary defect
- Central (midbrain) lesions of the light reflex
- Efferent parasympathetic defects of the light reflex
- Holmes–Adie syndrome
- Disorders of the sympathetic nervous supply to the pupil
- Horner’s syndrome
- References
- Further reading
- General texts
- Unilateral and bilateral visual failure
- Optic nerve disease
- Ocular involvement in other neurological diseases
- Diplopia
- Central disorders of eye movements
- Nystagmus
- Chiasmal and retrochiasmal disorders
- Disorders of higher visual function
- Pupils
- Dizziness and vertigo: introduction
- Epidemiology
- 15: Neuro‐Otology: Problems of Dizziness, Balance and Hearing
- Basic concepts
- Three‐dimensional spatial orientation
- Vestibulo‐ocular reflexes
- Encoding of head movements in space
- Neuro‐otological assessment
- Clinical examination
- What to examine
- When to examine what – the clinical presentation of balance disorders
- What to examine
- Brief neurological examination
- Gait and posture
- Nystagmus, eye movements, positional testing
- Cover test
- Spontaneous nystagmus
- Gaze evoked nystagmus
- Congenital nystagmus
- Smooth pursuit eye movements
- Saccadic eye movements
- Optokinetic nystagmus
- Vestibulo‐ocular reflexes
- Doll’s head eye manoeuvre
- Dynamic visual acuity
- Head impulse test
- Vestibulo‐ocular reflex suppression
- Positional manoeuvres, Dix–Hallpike and roll manoeuvres
- Orthostatic blood pressure
- When to examine what – the clinical presentation of balance disorders
- Acute vertigo
- Recurrent vertigo
- Chronic dizziness and/or unsteadiness
- Commonly used vestibular investigations
- Electronystagmograph
- Clinical relevance of ENG
- Rotary chair testing
- Types of rotary chair stimuli
- Clinical relevance of rotary chair testing
- Video‐oculography
- Caloric testing
- Principles of caloric testing
- Quantitative analysis
- Closed‐circuit and air caloric testing
- Clinical value of caloric testing
- Posturography
- Vestibular evoked myogenic potentials
- Clinical disorders
- Vestibular neuritis
- Aetiology
- Clinical assessment
- Neuro‐otological investigations
- Course
- Differential diagnosis of vestibular neuritis
- Benign paroxysmal positional vertigo
- Incidence of BPPV
- Posterior semicircular canal BPPV
- Horizontal canal BPPV – geometric type
- Apogeotropic horizontal canal BPPV
- Anterior canal BPPV
- Migraine‐related dizziness
- Definitions
- Basilar migraine
- Vestibular migraine
- Benign recurrent vertigo
- Ménière’s disease
- Bilateral vestibular failure
- Vestibular paroxysmia
- Motion sickness
- Management of vestibular disorders
- Drug treatment
- Symptomatic treatment of acute vestibular symptoms
- Specific treatment of vestibular disorders
- Migraine
- Episodic ataxia
- Central vestibular dysfunction
- Treatment of chronic peripheral vertigo
- Vestibular rehabilitation physiotherapy
- Particle repositioning procedures
- Psychological treatment
- Surgical management of vertigo
- Hearing disorders
- Anatomy and physiology
- Definitions and introduction
- Basic concepts
- Conductive hearing loss
- Sensorineural hearing loss
- Auditory neuropathy
- Brainstem auditory dysfunction
- Auditory processing disorder
- Clinical examination of the ear and hearing
- Otoscopy
- Auricle (pinna)
- External auditory meatus
- Tympanic membrane and middle ear
- Tuning fork tests
- Audiological investigations
- Baseline audiometric tests
- Pure‐tone audiometry
- Acoustic impedance measurements
- Speech audiometry
- Electro‐acoustic and electrophysiological tests
- Oto‐acoustic emissions
- Cochlear microphonics and electro‐cochleography
- Acoustic brainstem evoked responses
- Middle latency response
- Cortical‐evoked auditory responses
- Aetiology of hearing loss
- Conductive hearing loss
- Disorders of the tympanic membrane and middle ear
- Sensorineural hearing loss
- Genetic hearing loss
- Metabolic disease
- Drugs
- Acoustic trauma
- Autoimmune disorders (Table 15.12)
- Retro‐cochlear hearing disorders
- Charcot–Marie–Tooth disease
- Neurofibromatosis type 2
- Friedreich’s ataxia
- Refsum’s disease
- Mitochondrial disorders
- Inherited muscle disorders
- Acquired retro‐cochlear hearing disorders (Table 15.14)
- Extrinsic and intrinsic tumours of the cerebellopontine angle
- Multiple sclerosis
- Sarcoidosis
- Vascular disease
- Superficial siderosis
- Auditory processing disorders
- Aetiology of APD
- Cortical hearing impairment
- Auditory agnosia
- Interhemispheric lesions
- Management of auditory disorders
- Hearing aids
- Conductive hearing loss
- Sensorineural hearing loss
- VIIIth nerve disorders
- Amplification and rehabilitation strategies
- Auditory processing disorders
- Environmental modifications
- Signal enhancement strategies
- Relatives and carers: speaker‐based adaptations
- Auditory training programmes and compensatory strategies
- References
- Further reading
- 16: Spinal Column and Spinal Cord Disorders
- Spinal embryology, anatomy and physiology
- Embryology of the spine
- Genetic control of spinal development
- Identifying genetic mutations involved in spinal anomaly
- Anatomy and physiology of spinal maldevelopment
- Disorders of axonal guidance
- Congenital mirror movements
- Human vertebral segmentation defects
- Diagnosis of spinal column and spinal cord disorders
- Clinical assessment of spinal disorders
- Craniocervical junction
- Syringobulbia and syringomyelia
- Cervical spine
- Thoracic spine
- Lumbar and sacrococcygeal spine
- Other clinical features of spinal disease
- Diagnosis of spinal tumours
- Clinical features of vascular disorders of the spine
- Diagnosis of spinal vascular disease
- Radiological assessment of spinal disorders
- Specific diseases of the spinal column and spinal cord and their management
- Skeletal disorders affecting the spine
- Idiopathic scoliosis
- Congenital scoliosis
- Neuromuscular scoliosis
- Kyphosis and lordosis
- Miscellaneous causes of spinal deformity
- Management of spinal deformity
- Surgical correction of spinal deformity
- Cranio‐cervical junction anomalies
- Down’s syndrome
- Chiari malformations
- Congenital basilar invagination
- Os odontoideum
- Management of craniocervical junction anomalies
- Syringomyelia
- Spinal dysraphsim
- Klippel–Feil syndrome
- Rheumatological disorders affecting the spine and spinal cord
- Indications for surgical management of the rheumatoid spine
- Spondyloarthropathies
- Spinal trauma
- Acute management of spinal injury
- Spinal tumours
- Degenerative disease of the spine
- Low back pain and degenerative disc disease
- Spinal infections
- Spinal cord inflammation
- Vascular disorders of the spine
- Management of spinal vascular disease
- Metabolic diseases of the spinal cord
- Hereditary spastic paraplegia
- Miscellaneous conditions affecting the spine and spinal cord
- Further reading
- Physiology
- Spinal cord development and repair
- Spinal cord trauma
- Spinal tumours
- Rheumatoid diseases
- Infections
- Other medical conditions affecting the spinal cord
- Scoliosis
- Other surgical
- Degenerative spine disease
- 17: Cerebellar Ataxias and Related Conditions
- Approach to the patient with ataxia
- Symptoms
- Physical signs
- Additional signs
- The ataxic disorders
- Inherited ataxia syndromes
- Congenital ataxias
- Autosomal recessive cerebellar ataxias
- Friedreich’s ataxia
- Ataxic disorders associated with defective DNA repair
- Ataxias associated with oculomotor apraxia
- Ataxia caused by vitamin E deficiency
- Autosomal recessive spastic ataxia of Charlevoix‐Saguenay
- Other metabolic causes of ataxia
- Intermittent metabolic ataxias
- Progressive metabolic ataxias
- Autosomal dominant cerebellar ataxias
- Dentato‐rubro‐pallido‐luysian atrophy
- Investigations
- Treatment
- Genetic forms of episodic ataxia
- Episodic ataxia type 1
- Episodic ataxia type 2
- Other episodic ataxias
- X‐linked ataxia syndromes
- Mitochondrial ataxia syndromes
- Next generation gene sequencing
- Acquired ataxia syndromes
- Infective disease
- Acute or subacute onset
- Progressive ataxia with a chronic or subacute course
- Inflammatory disease
- Vascular disease
- Vascular anomalies
- Acquired metabolic disorders
- Toxins and physical agents
- Ethyl alcohol (ethanol)
- Drugs
- Solvents and solvent abuse
- Heavy metals
- Physical agents
- Paraneoplastic cerebellar degeneration
- Late onset cerebellar degenerations
- Multiple system atrophy
- Ataxia and sensitivity to gluten
- Idiopathic late onset ataxia
- Conclusions
- References
- Further reading
- 18: Restorative Neurology, Rehabilitation and Brain Injury
- The nature of disability and its optimal management
- Key aspects of multi‐dimensional rehabilitation
- Natural histories of neurological damage
- Disease/Health condition (organ disorder/pathology) (ICD-10) Subjective quality of life and well-being
- Impairments
- Activities
- Participation
- Resources, integrated care pathways, effectiveness and evidence base
- Neural reorganisation and restoration
- Treatment of neurological impairments and functional limitations
- Restorative and compensatory approaches, skill learning and task‐related training
- Physical therapeutic interventions for motor disorders
- Bobath approach and Motor Relearning Programme
- Impairment based treatment techniques
- Constraint induced movement therapy
- Balance and posture
- Treadmill training, functional electrical stimulation, cueing, fitness and mental imagery
- Robotics and virtual reality
- Language disorders: speech and language therapy and communication aids
- Visual loss and restorative therapies
- Cognitive impairments
- Environmental manipulation and compensatory strategies
- Restorative approaches
- Executive function, retraining and behavioural modification
- Telerehabilitation
- Vocational rehabilitation
- Medical treatments for specific problems
- Spasticity
- Ataxia
- Pain
- Bladder, bowel and sexual dysfunction
- Fatigue
- Dysphagia
- Neuropsychiatric problems
- Single incident brain injury
- Stroke
- Traumatic brain injury
- Service delivery
- Organisational behaviours and interdisciplinary assessment
- Assessment
- Goal‐setting
- Outcome measurement
- Indices of outcome
- Service quality
- Conclusions
- Further reading
- General texts
- Epidemiology
- Guidelines
- Restorative neurology
- Skill learning and task‐related training
- Physical therapeutic interventions for motor disorders
- Language disorders
- Visual loss
- Cognitive impairments
- Telerehabilitation
- Medical treatments
- Single incident brain injury Stroke
- Traumatic brain injury
- Organisational behaviours
- 19: Toxic, Metabolic and Physical Insults to the Nervous System and Inherited Disorders of Metabolism
- Neurological disorders associated with exposure to toxic substances
- Heavy metals
- Lead
- Mercury
- Arsenic
- Manganese
- Aluminium
- Thallium
- Tin
- Bismuth
- Solvents and toxins
- Toluene
- Trichloroethylene and tetrachlorethylene
- Ethylene oxide
- Hexacarbon solvents
- Xylene and styrene
- Carbon disulfide
- Cyanide
- Acrylamide and acylonitrile
- Allyl chloride
- Methyl bromide
- Methyl chloride
- Methyl alcohol (Methanol)
- Nitrous oxide
- Organophosphates
- Carbon monoxide
- Marine toxins
- Ingested toxins
- Other biological toxins
- Snake venom
- Spider toxins
- Scorpion toxin
- Ticks
- Fungal poisons
- Lathyrism
- Konzo
- Subacute myelo‐optico neuropathy
- Tropical myelo‐neuropathy
- Radiation‐induced neurological disease
- Therapeutic radiation
- Early‐delayed radiation encephalopathy
- Late‐delayed radiation encephalopathy
- Transient radiotherapy myelopathy
- Radiation plexopathy
- Lightning and electrical damage to the nervous system
- Mechanisms of lightning and other electrical damage
- Lightning: initiation and pattern of contact
- Electrical injuries: high and low‐voltage
- Nervous system complications of lightning and electrical injury
- Non‐nervous system complications of lightning and electrical injury
- Cardiac
- Skin and muscle damage
- Management
- Heat stroke
- Hypothermia and non‐freezing cold injury
- Diving
- Decompression sickness
- Arterial and venous gas emboli
- Altitude medicine
- Acute mountain sickness and cerebral oedema
- High altitude pulmonary oedema
- Neurobiological weapons
- Modes of release
- Nerve agents
- Organophosphates
- Other toxins and poisons
- Vitamin deficiencies and toxicity
- Vitamin A
- Vitamin B
- thiamine)
- Vitamin B
- niacin, nicotinic acid)
- Vitamin B
- pyridoxine)
- Vitamin B
- deficiency (see Chapter 16)
- Subacute combined degeneration of the cord
- Folate deficiency
- Vitamin D
- Vitamin E
- Alcohol abuse
- Metabolism of alcohol
- Effects of acute intoxication
- Effects of alcohol substitutes
- Methyl alcohol (methanol)
- Ethylene glycol
- Withdrawal syndromes
- Withdrawal seizures (‘rum fits’)
- Management of alcohol withdrawal
- Chronic disorders associated with prolonged alcohol abuse
- Wernicke’s encephalopathy
- Korsakoff’s syndrome
- Cerebellar ataxia
- Confusional state and dementia
- Alcoholic peripheral neuropathy
- Alcoholic myopathy
- Other neurological complications of alcohol abuse
- Marchiafava–Bignami syndrome
- Fetal alcohol syndrome
- Psychiatric sequelae
- Traumatic injury
- Compressive neuropathies (see Chapter 10)
- Amblyopia (see Chapter 14)
- Alcoholic cirrhosis
- Strachan’s syndrome
- Other deficiency states associated with neurological manifestations
- Copper deficiency
- Magnesium deficiency
- Drugs of abuse
- Epidemiology
- Stimulants
- Amphetamines
- Designer drugs
- Methylphenidate (Ritalin)
- Methcathinone analogues – khat
- MPTP
- Cocaine
- Conditions caused by stimulant abuse
- Sedatives
- Opiates
- Barbiturates
- Benzodiazepines
- Hallucinogens
- Lysergic acid diethylamide
- Marijuana
- Ketamine
- Phencyclidine (angel dust)
- GABA hydroxybutyrate
- Anticholinergics
- Solvents
- Athletic performance‐enhancing drugs
- Investigation of suspected substance abuse
- Adverse reactions to drugs
- Seizures
- Headache
- Confusional states
- Encephalopathy
- Memory disturbance
- Neuropsychiatric effects
- Coma
- Sleep disorders
- Toxic leukoencephalopthy
- Cerebrovascular disease
- Impairment of taste and small
- Drug‐induced movement disorders (Chapter 6)
- Ototoxicity
- Cerebellar disorders
- Visual disorders
- Autonomic effects
- Neuromuscular drug effects
- Peripheral neuropathy
- Drugs interfering with neuromuscular transmission
- Myalgia, stiffness and cramp
- Malignant hyperthermia
- Neuroleptic malignant syndrome
- Serotonin syndrome
- Tyramine cheese reaction
- Anticholinergic syndrome caused by medication toxicity
- Inherited disorders of metabolism
- Porphyria
- Acute intermittent porphyria
- Diagnosis
- Management
- Disorders of amino acid metabolism
- Phenylketonuria
- Organic acidemias
- Maple syrup urine disease
- Isovaleric acidemia
- Propionic acidemia and methylmalonic acidemia
- Disorders of homocysteine metabolism
- Transsulfuration defects
- Remethylation Trans-sulfuration
- Defects in intracellular cobalamin metabolism
- Urea cycle disorders
- Diagnosis
- Management
- Arginase deficiency
- Disorders of carbohydrate metabolism
- Glycogen storage diseases (the GSDs)
- Hepatic involvement in glycogen storage diseases
- Skeletal/cardiac muscle involvement in glycogen storage diseases
- Central nervous system involvement in glycogen storage diseases
- Galactosaemia
- Fatty acid oxidation defects
- Diagnosis
- Management
- Neurotransmitter disorders
- Clinical presentations
- Laboratory diagnosis
- Management
- Lysosomal storage disorders
- Glycosphingolipidoses
- Adult onset inherited leukodystrophies
- X‐linked adrenoleukodystrophy
- Krabbe disease
- Cerebrotendinous xanthomatosis
- Metachromatic leukodystrophy
- Hereditary diffuse leukoencephalopathy with neuroaxonal spheroids
- Alexander’s disease
- Vanishing white matter disease
- Pelizaeus–Merzbacher disease and Pelizaeus– Merzbacher‐like disease
- Peroxisomal disorders
- Refsum disease
- Disorders of phospholipid and glycosphingolipid biosynthesis
- Disorders of phospholipid synthesis
- Disorders of glycosphingolipid synthesis
- Acute neurological emergencies caused by inherited metabolic disease
- References
- Further reading
- Toxins
- Metabolic disorders
- Physical insults
- Drugs of abuse
- Inborn errors of metabolism
- 20: Disorders of Consciousness, Intensive Care Neurology and Sleep
- Consciousness
- States of impaired consciousness
- Causes of coma
- Initial assessment and management of coma
- Medical assessment
- Examination
- Level of consciousness
- Glasgow Coma Scale
- Assessment of neurological function
- Distinction of metabolic and toxic coma from structural coma
- Psychogenic unresponsiveness
- Outcome from coma
- Aetiology
- Depth of coma
- Duration of coma
- Presence of seizures
- Co‐morbidity
- Investigations
- Locked‐in syndrome
- Vegetative state
- Minimally conscious state
- Determining brain death
- Repetition of testing
- Neurological intensive care
- Indications for intensive care management of neurological patients
- Ventilatory failure associated with neurological disease
- Neurological indications for tracheal intubation and mechanical ventilation
- Mechanical ventilation
- Weaning
- Conditions requiring neurointensive care support
- Raised intracranial pressure
- Measurement of intracranial pressure
- Indications for intracranial pressure monitoring
- Management
- Cerebral herniation
- Herniation of the temporal lobe through the tentorium (uncal herniation)
- Central herniation of the brainstem
- Subfalcine herniation
- Upward transtentorial herniation
- Tonsillar herniation
- Traumatic brain injury
- Skull fractures
- Extradural haematoma
- Subdural haematoma
- Traumatic subarachnoid haemorrhage
- Haemorrhagic contusions and lacerations
- Intracerebral haematoma
- Diffuse axonal injury
- Cerebral ischaemia
- Intensive care management of TBI
- Hydrocephalus and shunts
- Investigations
- Management
- Stroke (Chapter 5)
- Middle cerebral artery occlusion
- Acute basilar occlusion
- Artery of Percheron
- Cerebellar infarcts
- Subarachnoid haemorrhage
- Supratentorial intracerebral haemorrhage (basal ganglia or lobar)
- Infratentorial intracranial haemorrhage (cerebellar or brainstem)
- Cerebral venous thrombosis
- Seizures (Chapter 7)
- Status epilepticus (SE)
- Acute bacterial meningitis
- Herpes simplex encephalitis
- Autoimmune encephalopathy
- Limbic encephalitis associated with neuronal surface antigens
- Morvan’s syndrome
- Encephalitis due to NMDA receptor antibodies
- Steroid responsive encephalopathy
- Other antibody‐mediated encephalomyelopathies
- Metabolic encephalopathy
- Septic encephalopathy
- Uraemic encephalopathy
- Hepatic encephalopathy
- Hyperpyrexia and hyperthermia
- Hypernatraemia
- Hyponatraemia
- Cerebral salt wasting
- Central pontine myelinolysis
- Posterior reversible encephalopathy syndrome
- Hypoxic–ischaemic brain injury
- Prognostic factors following cardiac arrest
- Seizures
- Longer‐term complications of HIBI
- Movement disorder emergencies
- Stiff person syndromes and progressive encephalopathy with rigidity and myoclonus
- Acute dystonia
- Stridor
- Cervical cord disorders (Chapter 16)
- Anterior horn cell disease
- Neuromuscular disease
- Neuropathies (Chapter 10)
- Neuromuscular junction disease
- Muscle disease
- Tetanus (Chapter 9)
- Rabies (Chapter 9)
- General medical care on the NICU
- Nosocomial infection and infection surveillance
- Anticoagulation
- Delirium
- Patient comfort
- Pain
- Communication
- Sleep
- Communication with the family
- End of life issues on intensive care
- Neurology of general critical care
- Failure to awaken/depressed conscious state
- Weakness and failure to wean from mechanical ventilation
- Sleep and its disorders
- Structure of normal sleep
- REM sleep
- Patterns of sleep
- Regulation of wakefulness and sleep
- Functions of sleep
- Sleep and breathing
- Classification of sleep disorders
- Insomnia
- Management
- Sleep‐related breathing disorders
- Obstructive sleep apnoea/hypopnoea syndrome
- Hypersomnias of central origin
- Primary (idiopathic) hypersomnia
- Recurrent hypersomnia
- Idiopathic recurring stupor
- Excessive daytime somnolence in neurological disease
- Narcolepsy
- Cataplexy
- Hypnogogic/hypnopompic hallucinations
- Sleep paralysis and automatic behaviours
- Pathophysiology of narcolepsy
- Investigations
- Management of narcolepsy
- Circadian rhythm disorders
- Delayed or advanced sleep phase syndrome
- Shift work and jet lag
- Parasomnias
- Non‐REM parasomnias
- REM sleep disorders
- Other forms of parasomnia
- Sleep‐related movement disorders
- Restless legs syndrome
- Periodic limb movements of sleep
- Rhythmic movement disorders
- Isolated symptoms, apparently normal variants
- Other sleep disturbances in extrapyramidal disease
- Epilepsy syndromes associated with sleep
- Traumatic brain injury and sleep
- Acknowledgement
- References
- Further reading
- States of impaired consciousness
- Brain death
- Neurological intensive care
- Encephalopathy
- Neuromuscular
- Sleep
- 21: Neuro‐Oncology
- Epidemiology of common primary intracranial tumours
- Incidence
- Survival
- Risk factors
- Clinical features
- Headache
- Seizures
- Focal deficits
- Brainstem symptoms
- Cognitive and behavioural symptoms
- Endocrine symptoms
- Rare presentations
- Histogenesis of brain cancer
- Molecular mechanisms involved in tumour formation
- Genetic components in oncogenesis
- Epigenetic events in oncogenesis
- WHO classification of CNS tumours
- Neuroepithelial tumours
- Imaging of brain tumours
- Structural imaging
- Physiological imaging
- Diffusion‐weighted imaging
- Perfusion‐weighted imaging
- Permeability imaging (Ktrans)
- MR spectroscopy
- Functional MRI
- Applications of physiological imaging
- Distinguishing between astrocytomas and oligodendrogliomas
- Distinguishing between low‐grade and high‐grade gliomas
- Imaging of peri‐tumoural tissue
- Monitoring tumour growth and response to treatment
- Pseudoprogression and pseudoresponse
- Imaging the effects of radiotherapy
- Radiation‐induced leukoencephalopathy
- Radiation necrosis
- Optic neuropathy
- Radiation‐induced tumours
- Imaging complications of chemotherapy
- Multidisciplinary management of brain tumours
- Improving outcome and quality of life
- Surgical management
- General principles
- Surgical instrumentation and methods
- Radiotherapy
- Radiotherapy planning
- Radiation neurotoxicity
- High‐grade gliomas
- Pathology
- Anaplastic astrocytoma
- Glioblastoma
- Imaging
- Anaplastic astrocytoma
- Glioblastoma
- Surgery
- Radiotherapy
- Chemoradiation
- Chemotherapy
- Relapsed high‐grade gliomas
- Anaplastic oligodendrogliomas
- Low‐grade gliomas
- Pathology
- Pilocytic astrocytoma
- Diffuse astrocytoma
- Oligodendroglioma
- Oligoastrocytoma
- Imaging
- Pilocytic astrocytoma
- Diffuse astrocytoma
- Oligodendroglioma
- Surgery for low‐grade gliomas
- Pilocytic astrocytoma
- Diffuse astrocytoma and oligodendroglioma
- Radiotherapy for low‐grade gliomas
- Chemotherapy for low‐grade gliomas
- Other low‐grade tumours in childhood
- Tumours of predominantly neuronal cell origin
- Gangioglioma and gangliocytoma
- Central neurocytoma
- Dysembryoplastic neuroepithelial tumour
- Choroid plexus tumours
- Meningiomas
- Pathology
- Imaging
- Surgery
- Radiotherapy
- Chemotherapy
- Brain metastases
- Pathology
- Imaging
- Surgery and/or radiotherapy
- Chemotherapy
- Primary spinal cord tumours
- Surgery
- Chemotherapy for intrinsic cord tumours
- Spinal ependymomas
- Spinal astrocytomas
- Spinal meningiomas and schwannomas
- Metastatic spinal cord compression
- Skull base tumours
- Chordoma
- Pathology
- Imaging
- Treatment
- Chondrosarcoma
- Neurofibromatosis and schwannomas
- Pathology
- Molecular genetics
- Clinical features
- Skull base meningiomas
- Pituitary tumours
- Biological behaviour
- Size
- Histology
- Functional criteria
- Clinical presentation
- Pituitary apoplexy
- Drug therapy and surgery
- Radiotherapy
- Craniopharyngioma
- Primary CNS lymphomas
- Imaging
- Pathology
- Clinical presentation
- Diagnosis
- Treatment
- Primitive neuroepithelial tumours and medulloblastomas
- Pathology
- Molecular genetics and histogenesis of medulloblastoma
- Imaging
- Clinical features
- Treatment
- Pineal region tumours
- Introduction
- Pathology
- Clinical features
- Treatment
- Germ cell tumours
- Optic pathway glioma
- Treatment of optic pathway glioma
- Ependymomas
- Pathology
- Imaging
- Treatment
- Dermoids and epidermoid cysts
- Imaging
- Haemangioblastomas
- Colloid cysts, Rathke’s pouch tumours and neuro‐enteric cysts
- Neurological complications of cancer
- Direct effects and infiltration
- Metastases
- Malignant meningitis
- Clinical features
- Diagnosis
- Treatment
- Indirect effects of cancer
- Toxic and metabolic encephalopathy
- Vascular disorders
- Non‐bacterial thrombotic endocarditis
- CNS infections in cancer patients
- Paraneoplastic neurological disorders
- Incidence and prevalence
- Clinical features
- Paraneoplastic cerebellar degeneration
- Paraneoplastic encephalomyelitis and limbic encephalitis
- Brainstem encephalitis
- Paraneoplastic encephalomyelitis with rigidity
- Paraneoplastic opsoclonus‐myoclonus
- Paraneoplastic retinal degeneration
- Necrotising myelopathy
- Motor neurone syndromes
- Paraneoplastic sensory neuronopathy
- Paraneoplastic neuropathies
- Neuromyotonia
- Lambert–Eaton myasthenic syndrome
- Myasthenia gravis
- Polymyositis and dermatomyositis
- Acute necrotising myopathy
- Diagnosis of PND
- Paraneoplastic antineuronal autoantibodies
- Imaging
- Treatment for PND
- Neurological complications of chemotherapy
- Polyneuropathy
- Encephalopathy
- Further reading
- Epidemiology
- Clinical features
- Pathology
- Imaging
- Surgery, radiotherapy and chemotherapy
- Quality of life
- Paraneoplastic neurological syndromes
- Malignant meningitis
- Brain tumour charities and support services
- 22: Neuropsychiatry
- The mental state examination
- Appearance and behaviour
- Speech
- Mood and affect
- Thoughts
- Formal thought disorder
- Thought content
- Perceptions
- Cognition
- Insight
- Formulation
- Identifying and managing risk secondary to abnormal mental states
- Agitation and aggression
- Lack of insight
- Suicidal ideation/suicidal behaviour
- Legal issues: use of mental health and capacity acts
- Psychiatric symptoms commonly seen in neurological disorders
- Personality change
- Obsessions and compulsions
- Anxiety
- Mood
- Pseudodementia
- Psychosis
- Catatonia
- Non‐organic disorders in neurology
- Functional neurological symptoms
- Terminology
- Diagnosis
- Specific types of functional neurological symptoms
- Functional seizures
- Fixed dystonia
- Treatment of functional neurological symptoms
- Dissociative disorders
- Dissociative amnesia
- Dissociative fugue
- Depersonalisation/derealisation disorder
- Psychiatric disorders of epilepsy
- Peri‐ictal and ictal psychiatric symptoms
- Inter‐ictal psychiatric disorders
- Forced normalisation
- Personality changes in epilepsy
- Psychotropic effects of anticonvulsants
- Neuropsychiatric aspects of movement disorders
- Parkinson’s disease
- Depression
- Anxiety
- Apathy
- Psychosis
- Cognitive impairment
- Iatrogenic neuropsychiatric problems
- Other movement disorders
- Neuropsychiatric aspects of white matter disorders
- Minor head injury and post‐concussion syndrome
- Acknowledgement
- Further reading
- General
- Functional neurological symptoms
- Epilepsy
- Movement disorders
- 23: Pain
- Definitions
- Mechanisms of neuropathic pain
- Peripheral neuropathy
- Abnormal ion channel expression
- Spinal cord
- Central sensitisation and ‘wind‐up’
- Excitatory mechanisms
- Inhibitory mechanisms
- Role of inflammation and the immune system
- Supraspinal influences
- Assessment of pain in the patient with neurological disease
- The pain history
- Treatment history
- Physical examination
- Central spinal pain: some anatomical and pathological considerations
- Pain in individual disorders of the central nervous system
- Multiple sclerosis
- Neuropathic paroxysmal pain
- Neuropathic non‐paroxysmal pain
- Nociceptive pain
- Parkinson’s disease
- Neuropathic (central) pain
- Dystonia/dyskinesia pain
- Central post‐stroke pain
- Spinal cord injury
- Syringomyelia
- Phantom pain
- Painful legs and moving toes syndrome
- Epilepsy
- Fibromyalgia
- Peripheral pain: anatomical and pathological considerations (Chapter 2)
- Pain in individual disorders of the peripheral nervous system
- Painful peripheral neuropathies
- Burning feet, and the small‐diameter fibre neuropathies
- Erythromelalgia
- Treatment
- Neuropathy in diabetes mellitus (Chapter 10)
- Shingles and post‐herpetic neuralgia: shingles
- Post‐herpetic neuralgia
- Guillain–Barré syndrome
- Neuralgic amyotrophy (brachial neuritis)
- Painful inherited neuropathies
- Latrogenic painful peripheral nerve lesions
- Complex regional pain syndrome
- Pain associated with benign orthopaedic conditions
- Glomus tumour
- Osteoid osteoma
- Motor neurone disease
- Painful peripheral viscero‐somatic disorders
- Burning mouth syndrome
- Vulvodynia
- Visceral pain
- Plexopathies
- Traumatic brachial plexus lesions
- Malignant and radiation‐induced plexopathies
- Management
- Management of neuropathic pain
- Systemic drug treatments
- Opioids and other analgesics
- Antidepressants
- Antiepileptics
- Local anaesthetics and related compounds
- NMDA receptor antagonists
- Cannabinoids
- Topical agents
- Botulinum toxin
- Intrathecal drugs
- Neuro‐ablative and neuro‐stimulation procedures
- Neuro‐ablative procedures
- Neuro‐stimulation procedures
- Other physical methods of treatment
- Acupuncture
- Psychological approaches to management of chronic pain
- The placebo phenomenon
- Insensitivity to pain
- Congenital insensitivity to pain
- Transient indifference to pain
- Conclusions
- Acknowledgement
- References
- Further reading
- General
- Classic papers on pain
- Clinical assessment
- Specific Conditions
- Treatment and the placebo response
- 24: Autonomic Aspects of Neurology
- Classification of autonomic dysfunction
- Clinical features
- Cardiovascular system
- Orthostatic hypotension
- Syncope without orthostatic hypotension
- Orthostatic intolerance with posturally induced tachycardia
- Hypertension
- Heart rate disturbances
- Facial and peripheral vascular changes
- Sudomotor system
- Alimentary system
- Kidneys and urinary tract
- Sexual function
- Eyes and lacrimal glands
- Respiratory system
- Additional features of neurological conditions: MSA and Parkinson’s disease
- Psychological and psychiatric disturbances
- Clinical examination
- Investigations
- Management
- Cardiovascular system
- Orthostatic hypotension
- Supine hypertension
- Autonomic mediated syncope
- Postural tachycardia syndrome
- Hypertension
- Sudomotor disorders
- Anhidrosis
- Hyperhidrosis
- Alimentary system
- Urinary tract
- Sexual function and the reproductive system
- Respiratory system
- Eye and lacrimal glands
- Treatment in MSA and Parkinson’s disease
- References
- Further reading
- 25: Uroneurology
- The lower urinary tract and its neurological control
- Lower urinary tract dysfunction following neurological disease
- Cortical disease
- Cerebrovascular disease
- Dementia
- Parkinson’s disease
- Multiple system atrophy
- Brainstem lesions
- Spinal cord disease
- Multiple sclerosis
- Other (non‐traumatic) spinal cord diseases
- Sacral and infrasacral lesions
- Conus or cauda equina lesions
- Diabetic neuropathy
- Other neuropathies
- Pelvic nerve injury
- Myotonic dystrophy
- Urinary retention
- Urinary retention in women
- Management of lower urinary tract dysfunction
- Management of storage dysfunction
- Antimuscarinics (anticholinergics)
- Desmopressin
- Botulinum toxin
- Neuromodulation
- Management of voiding dysfunction
- Sexual functions and its neurological control
- Physiology
- Sexual dysfunction following neurological disease
- Traumatic brain injury
- Stroke
- Epilepsy
- Parkinson’s disease
- Multiple system atrophy
- Spinal cord injury
- Multiple sclerosis
- Lesions of the sympathetic thoraco‐lumbar outflow
- Conus or cauda equina lesions
- Peripheral neuropathies
- Management of sexual dysfunction
- References
- Further reading
- 26: Systemic Conditions and Neurology
- Aortic and cardiac disorders
- Aortic pathology
- Anatomy
- Blood supply
- Cerebral ischaemia resulting from aortic disease
- Spinal cord ischaemia resulting from aortic disease
- Neurological complications of cardiac surgery
- Neurological complications of acquired cardiac disease
- Cardiac embolism
- Rhythm disturbances
- Cardiomyopathies
- Valve disease
- Atrial myxoma
- Endocrine conditions
- Thyroid disorders
- Hyperthyroidism
- Hypothyroidism
- Neurological aspects of Hashimoto’s thyroiditis
- Diabetes mellitus
- Acute metabolic disturbances
- Diabetic neuropathies
- Pituitary disorders
- Inappropriate antidiuretic hormone secretion and cerebral salt wasting
- Parathyroid disorderss
- Adrenal disorders
- Electrolyte disturbances
- Sodium
- Potassium
- Calcium and magnesium
- Haematological disorders
- Anaemias
- Proliferative conditions
- Leukaemias
- Plasma cell dyscrasias
- Lymphomas
- Langerhans cell histiocytosis
- Polycythaemia
- Thrombocythaemia
- Bleeding disorders
- Thrombotic thrombocytopenic purpura
- Coagulation disorders
- Primary immunodeficiency
- Gastrointestinal disorders
- Hepatic encephalopathy
- Vitamin deficiencies causing neurological disorders
- Vitamin B
- deficiency
- Vitamine B
- niacin) deficiency (Pellagra)
- Vitamin D deficiency
- Vitamin E deficiency
- Malabsorption
- Coeliac disease
- Inflammatory bowel disease
- Renal disease
- Conditions affecting both renal and neurological function
- Neurological consequences of renal disease and its treatment
- Uraemic encephalopathy
- Dialysis encephalopathy
- Dialysis disequilibrium syndrome
- Neuropathy associated with renal disease
- Neurological aspects of organ transplantation
- CNS infections
- Viral infection
- Bacterial infection
- Fungal infection
- Parasitic infection
- Neurological sequelae of transplantation
- Seizures
- Encephalopathy
- Stroke
- Medication
- CNS malignancy
- Neuro‐ophthalmological problems
- Movement disorders
- Neuromuscular problems
- Complications related to specific allograft transplantation
- Renal transplantation
- Liver transplantation
- Cardiac transplantation
- Lung transplantation
- Bone marrow transplantation
- Neurological involvement in systemic vasculitides and related disorders
- Pathological mechanisms
- Diagnosis and treatment of vasculitides involving the nervous system
- Polyarteritis nodosa and related conditions
- Granulomatosis with polyangiitis (Wegener’s granulomatosis)
- Giant cell arteritis
- Isolated cerebral angiitis
- Rheumatoid arthritis
- Systemic lupus erythematosus
- Antiphospholipid syndrome
- Sjögren’s syndrome
- Miscellaneous cerebral arteriopathies
- CADASIL
- CARASIL
- Fabry’s disease
- Susac’s syndrome
- Sneddon’s syndrome
- Degos’ disease
- HANAC
- Reversible cerebral vasoconstriction syndrome
- Sarcoidosis
- Clinical features and investigation
- Cranial neuropathy
- Meningeal and parenchymatous sarcoid
- Sarcoid encephalopathy
- Peripheral neuromuscular sarcoid
- Diagnosis
- Prognosis
- Behçet’s syndrome
- Epidemiology and pathology
- Patterns of nervous system involvement
- CNS involvement: parenchymal
- Cerebral venous sinus thrombosis
- Investigation
- Pathergy test in Behçet’s disease
- Treatment
- IgG4‐related disease
- CLIPPERS
- Neurocutaneous syndromes
- Neurofibromatosis type 1 (von Recklinghausen’s disease)
- Neurofibromatosis type 2
- Xeroderma pigmentosa
- Tuberous sclerosis
- Von Hippel–Lindau disease
- Ataxia telangiectasia
- Sturge–Weber syndrome
- Neurological aspects of pregnancy
- Epilepsy and women of childbearing age
- Fertility
- Pregnancy
- Epilepsy and the fetus
- Teratogenicity of antiepileptic drugs
- Puerperium
- Reducing risks of pregnancy to mother and child
- Cerebrovascular disorders in pregnancy
- Pregnancy and other neurological diseases
- Pituitary disorders
- Headache
- Neuromuscular disorders
- Multiple sclerosis
- Chorea gravidarum
- Tumours
- Idiopathic intracranial hypertension
- Complications of obstetric anaesthesia
- Postpartum compression neuropathies
- Other conditions causing acute neurological symptoms during pregnancy
- Palliative and end of life care in neurology
- The dying patient
- References
- Further reading
- Cardiovascular disorders
- Endocrine disorders
- Haematological disorders
- Gastro‐intestinal disorders
- Renal disease
- Vasculitis
- Neurosarcoidosis, Sjögren
- Behçet’s syndrome
- Neurocutaneous disorders
- Pregnancy
- Palliative care
- Index
Advertisement
Add Comment
Please, Sign In to add comment
Advertisement